These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9551207)

  • 1. Bleomycin.
    Lazo JS; Sebti SM
    Cancer Chemother Biol Response Modif; 1997; 17():40-5. PubMed ID: 9551207
    [No Abstract]   [Full Text] [Related]  

  • 2. Bleomycin.
    Lazo JS
    Cancer Chemother Biol Response Modif; 1999; 18():39-45. PubMed ID: 10800476
    [No Abstract]   [Full Text] [Related]  

  • 3. [General pharmacology of bleomycin in various animal species].
    De Natale G; Soscia A; Preziosi P
    Boll Soc Ital Biol Sper; 1972 Mar; 48(6):118-21. PubMed ID: 4115896
    [No Abstract]   [Full Text] [Related]  

  • 4. Bleomycin.
    Lazo JS; Sebti SM
    Cancer Chemother Biol Response Modif; 1994; 15():44-50. PubMed ID: 7540032
    [No Abstract]   [Full Text] [Related]  

  • 5. Bleomycin-induced pulmonary fibrosis susceptibility genes in AcB/BcA recombinant congenic mice.
    Lemay AM; Haston CK
    Physiol Genomics; 2005 Sep; 23(1):54-61. PubMed ID: 16179420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the effects of alpha-tocopherol on the levels of Fe, Cu, Zn, Mn, and carbonic anhydrase in rats with bleomycin-induced pulmonary fibrosis.
    Ertekin A; Deger Y; Mert H; Mert N; Yur F; Dede S; Demir H
    Biol Trace Elem Res; 2007 Jun; 116(3):289-300. PubMed ID: 17709909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
    Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
    Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine.
    Nici L; Santos-Moore A; Kuhn C; Calabresi P
    Cancer; 1998 Nov; 83(9):2008-14. PubMed ID: 9806661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleomycins.
    Lazo JS; Sebti SM
    Cancer Chemother Biol Response Modif; 1992; 13():53-8. PubMed ID: 1382529
    [No Abstract]   [Full Text] [Related]  

  • 10. Animal models of pulmonary fibrosis.
    Gharaee-Kermani M; Ullenbruch M; Phan SH
    Methods Mol Med; 2005; 117():251-9. PubMed ID: 16118457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin-3-gallate exhibits anti-fibrotic effect by attenuating bleomycin-induced glycoconjugates, lysosomal hydrolases and ultrastructural changes in rat model pulmonary fibrosis.
    Sriram N; Kalayarasan S; Sudhandiran G
    Chem Biol Interact; 2009 Jul; 180(2):271-80. PubMed ID: 19497426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin.
    Kradin RL; Sakamoto H; Jain F; Zhao LH; Hymowitz G; Preffer F
    Exp Mol Pathol; 2004 Jun; 76(3):205-11. PubMed ID: 15126102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory related changes in lung tissue mechanics after bleomycin-induced lung injury.
    Pinart M; Serrano-Mollar A; Negri EM; Cabrera R; Rocco PR; Romero PV
    Respir Physiol Neurobiol; 2008 Feb; 160(2):196-203. PubMed ID: 17981520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transforming growth factor-beta type I and type II receptors is altered in rat lungs undergoing bleomycin-induced pulmonary fibrosis.
    Zhao Y; Shah DU
    Exp Mol Pathol; 2000 Oct; 69(2):67-78. PubMed ID: 11001857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parabiosis and transplantation models show no evidence of circulating dermal fibroblast progenitors in bleomycin-induced skin fibrosis.
    Boban I; Barisic-Dujmovic T; Clark SH
    J Cell Physiol; 2008 Jan; 214(1):230-7. PubMed ID: 17579342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Azoulay E; Herigault S; Levame M; Brochard L; Schlemmer B; Harf A; Delclaux C
    Crit Care Med; 2003 May; 31(5):1442-8. PubMed ID: 12771616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung interleukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis.
    Gharaee-Kermani M; Nozaki Y; Hatano K; Phan SH
    Cytokine; 2001 Aug; 15(3):138-47. PubMed ID: 11554783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleomycin resistance in mammalian cells expressing a genetic suppressor element derived from the SRPK1 gene.
    Sanz G; Mir L; Jacquemin-Sablon A
    Cancer Res; 2002 Aug; 62(15):4453-8. PubMed ID: 12154054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental pulmonary fibrosis induced by bleomycin].
    Okamoto T; Amano T; Wada T; Harada M; Tanaka T
    Igaku To Seibutsugaku; 1970 Jun; 80(6):299-301. PubMed ID: 5465518
    [No Abstract]   [Full Text] [Related]  

  • 20. Bleomycins.
    Lazo JS; Sebti SM
    Cancer Chemother Biol Response Modif; 1993; 14():37-44. PubMed ID: 7508730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.